Glenview Trust’s Core Laboratories CLB Stock Holding History

Glenview Trust’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,378	Closed	-$251K	–	344
2019 Q3	$251K	Hold	5,378	–	–	0.02%	312
2019 Q2	$281K	Hold	5,378	–	–	0.02%	292
2019 Q1	$371K	Hold	5,378	–	–	0.02%	260
2018 Q4	$321K	Hold	5,378	–	–	0.02%	266
2018 Q3	$623K	Hold	5,378	–	–	0.04%	210
2018 Q2	$679K	Sell	5,378 -770	-13%	-$93.7K	0.05%	184
2018 Q1	$665K	Hold	6,148	–	–	0.05%	206
2017 Q4	$674K	Hold	6,148	–	–	0.05%	207
2017 Q3	$607K	Hold	6,148	–	–	0.04%	210
2017 Q2	$623K	Hold	6,148	–	–	0.05%	199
2017 Q1	$710K	Hold	6,148	–	–	0.06%	189
2016 Q4	$738K	Buy	+6,148	New	+$681K	0.06%	183

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Glenview Trust's CLB Position: Q4 2019 in Review

Glenview Trust sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 5,378 shares — an estimated $251K sold.

Glenview Trust first reported a position in CLB in Q4 2016 and held it in 12 quarters. The position peaked at $738K in Q4 2016. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

Glenview Trust reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
Glenview Trust sold 5,378 Core Laboratories shares in Q4 2019, an estimated $251K.
Glenview Trust first reported a position in Core Laboratories in Q4 2016 and held it in 12 quarters.
Glenview Trust's Core Laboratories position peaked at $738K in Q4 2016.
283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Glenview Trust's 13F filing for Q4 2019, filed 6 Feb 2020.